HURA (TuHURA Biosciences) Short Percentage of Float


HURA TuHURA Biosciences Inc HURA
12 GF Score
Price $2.48
! 1 Warning Sign
View Full Analysis

What is TuHURA Biosciences Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

HURA vs AGEN, CRBP, SPRB: Short Percentage of Float Comparison

For the Biotechnology subindustry, TuHURA Biosciences's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

TuHURA Biosciences Short Percentage of Float vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, TuHURA Biosciences's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where TuHURA Biosciences's Short Percentage of Float falls into.


HURA
12GF Score
TuHURA Biosciences Inc HURA
Short Percentage of Float is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

TuHURA Biosciences Business Description

Other Exchanges PL3:Germany
Address 10500 University Center Drive, Suite 110, Tampa, FL, USA, 33612
TuHURA Biosciences Inc is a phase 3 clinical stage immuno-oncology company with three distinct technologies focused on the development of novel therapeutics designed to overcome primary and acquired resistance to cancer immunotherapies. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. The company operates in one reportable segment, which includes all activities related to advancing therapies for cancer treatment.
12GF Score

Get the complete analysis for HURA

Short Percentage of Float is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.48
Price